Study of Oral Treatments for Hepatitis C

NCT02786537 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1275

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: SOF/LDV (sofosbuvir/ledipasvir)
DRUG: PrOD (ombitasvir/paritaprevir/ritonavir with dasabuvir) (Phase 1 only)
DRUG: EBR/GZR (elbasvir/grazoprevir)
DRUG: Ribavirin

Sponsor

University of Florida

Collaborators

[object Object]
[object Object]
[object Object]